The report “Global Single-Cell Genome Sequencing Market, By Type (Reagents and Instruments), By Technology (NGS, PCR, qPCR, MDA, and Microarray), By Application (Circulating Cells, Genomic Variation, Cell Differentiation, Subpopulation Characterization, and Others), By End-User (Forensic Labs, Cell banks and IVF centers, Academic & Research Laboratories, Biotechnology & biopharmaceutical companies, and Hospitals and diagnostic laboratories) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
• In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been produced for solidified designated DNA and RNA improvement and investigations. These boards save time and save tests that are of restricted accessibility.
• In July 2019, QIAGEN collaborated with Illumina with the plan to widen the accessibility and utilization of NGS-situated in vitro symptomatic (IVD) units.
• In June 2019, Beckman Coulter obtained Cytobank, Inc. (US) to coordinate Cytobank's product into Beckman Coulter's item portfolio to give inventive answers for clients.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-SingleCell-Genome-Sequencing-Market-78
Key Market Insights from the report:
The global Single-Cell Genome Sequencing market accounted for US$ 1.47 billion in 2020 and is estimated to be US$ 4.72 billion by 2030 and is anticipated to register a CAGR of 13.1%. The global single-cell genome sequencing market has been segmented on the basis of type, technology, application, end-user, and region.
• By Type, the Global Single-Cell Genome Sequencing Market is segmented into Reagents and Instruments.
• By Technology, the Global Single-Cell Genome Sequencing Market is segmented into NGS, PCR, qPCR, MDA, and Microarray.
• By Application, the Global Single-Cell Genome Sequencing Market is segmented into Circulating Cells, Genomic Variation, Cell Differentiation, Subpopulation Characterization, and Others.
• By End-User, the Global Single-Cell Genome Sequencing Market is segmented into Forensic Labs, Cell banks and IVF centers, Academic & Research Laboratories, Biotechnology & biopharmaceutical companies, and Hospitals and diagnostic laboratories.
• By region, the Global Single-Cell Genome Sequencing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:
Key players operating in the global market of single-cell genome sequencing include ThermoFisher Scientific, Inc., Illumina, Bio-Rad, BD, Pacific Biosciences of California, Inc., QIAGEN, 10X Genomics, Inc., BGI, Novogene Co. Ltd., NuGEN Technologies, Inc., Takara Bio, Inc., F Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, Fludigim, and Agilent Technologies Inc.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

To know more
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]